perfosfamide has been researched along with Leukemia, Myeloid in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.25) | 18.7374 |
| 1990's | 12 (75.00) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adams, D; Carawan, H; Chao, NJ; Colvin, MO; Dodge, R; Gasparetto, C; Koh, LP; Loftis, J; Long, GD; Morris, A; Reese, M; Rizzieri, DA; Smith, CS; Talbot, JT; Vredenburgh, JJ; Waters-Pick, B | 1 |
| Appelbaum, FR; Bensinger, WI; Buckner, CD; Demirer, T; Gooley, T; Lilleby, K; Petersen, FB; Rowley, S; Sanders, J; Storb, R | 1 |
| Rowley, SD | 1 |
| Ball, ED; Malley, V; Rubin, J | 1 |
| Bhalla, K; Bullock, G; Huang, Y; Ibrado, AM; Lutzky, J; Mahoney, ME; Tang, C; Tourkina, E | 1 |
| Adachi, K; Marunouchi, T; Saito, H; Towatari, M | 1 |
| Damon, LE; Linker, CA; Ries, CA; Rugo, HS; Wolf, JL | 1 |
| Brugarolas, A; Perez-Calvo, J | 1 |
| Armitage, JO; Calderwood, S; Harris, RE; Horowitz, MM; Jones, RJ; Keating, A; Klein, JP; Lazarus, HM; Linker, CA; Miller, CB; Piantadosi, S; Rowlings, PA; Sobocinski, KA; Weisdorf, D; Zhang, MJ | 1 |
| Ambinder, RF; Braine, H; Brodsky, RA; Flinn, IW; Fuchs, EJ; Fuller, D; Gore, SD; Jones, RJ; Lee, SM; Miller, CB; Noga, SJ; O'Donnell, PV; Piantadosi, S; Smith, BD; Vala, MS; Vogelsang, GB | 1 |
| Rosenfeld, CS | 1 |
| Bhalla, K; Bullock, G; Holladay, C; Ibrado, AM; Jasiok, M; Lutzky, J; Singh, S | 1 |
| Wiley, JM; Yeager, AM | 1 |
| Arlin, Z; Bhalla, K; Grant, S; Howe, CW | 1 |
| Andersson, BS; Farquhar, D; McCredie, KB; Wang, YQ | 1 |
| Degliantoni, G; Mangoni, L; Rizzoli, V | 1 |
1 trial(s) available for perfosfamide and Leukemia, Myeloid
| Article | Year |
|---|---|
4-hydroperoxycyclophosphamide--purged peripheral blood stem cells for autologous transplantation in patients with acute myeloid leukemia.
Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Hematopoiesis; Hematopoietic Stem Cell Mobilization; Humans; Leukemia, Myeloid; Leukocytes, Mononuclear; Male; Maximum Tolerated Dose; Middle Aged; Neoplastic Cells, Circulating; Peripheral Blood Stem Cell Transplantation; Remission Induction; Survival Analysis; Transplantation, Autologous | 2003 |
15 other study(ies) available for perfosfamide and Leukemia, Myeloid
| Article | Year |
|---|---|
Influence of total nucleated cell dose from marrow harvests on outcome in patients with acute myelogenous leukemia undergoing autologous transplantation.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Agents; Bone Marrow Cells; Bone Marrow Purging; Bone Marrow Transplantation; Cell Count; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Female; Graft Survival; Humans; Infant; Leukemia, Myeloid; Male; Middle Aged; Regression Analysis; Remission Induction; Retrospective Studies; Survival Analysis; Transplantation, Autologous; Treatment Outcome | 1995 |
Bone marrow purging, 4-hydroperoxycyclophosphamide, and the FDA.
Topics: Acute Disease; Bone Marrow; Bone Marrow Purging; Clinical Trials as Topic; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cyclophosphamide; Drug Industry; Drug Utilization; Ethics, Medical; Humans; Leukemia, Myeloid; Multicenter Studies as Topic; Neoplasm, Residual; Treatment Outcome; United States; United States Food and Drug Administration | 1993 |
A combination of anti-CD15 monoclonal antibody PM-81 and 4-hydroperoxycyclophosphamide augments tumor cytotoxicity while sparing normal progenitor cells.
Topics: Acute Disease; Antibodies, Monoclonal; Bone Marrow Purging; Combined Modality Therapy; Cyclophosphamide; Cytotoxicity, Immunologic; Hematopoietic Stem Cells; Humans; Leukemia; Leukemia, Myeloid; Leukocytes, Mononuclear; Lewis X Antigen; Tumor Cells, Cultured | 1994 |
Effect of combined treatment with interleukin-3 and interleukin-6 on 4-hydroperoxycyclo-phosphamide-induced programmed cell death or apoptosis in human myeloid leukemia cells.
Topics: Apoptosis; Blotting, Southern; Bone Marrow Purging; Cyclophosphamide; DNA, Neoplasm; Gene Expression; Genes, jun; Genes, myc; Humans; Interleukin-3; Interleukin-6; Leukemia, Myeloid; RNA, Neoplasm; Tumor Cells, Cultured | 1993 |
Evidence for a critical role of DNA topoisomerase IIalpha in drug sensitivity revealed by inducible antisense RNA in a human leukaemia cell line.
Topics: Antibiotics, Antineoplastic; Antigens, Neoplasm; Antineoplastic Agents, Phytogenic; Blotting, Southern; Cell Survival; Cyclophosphamide; Daunorubicin; DNA Topoisomerases, Type II; DNA-Binding Proteins; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Etoposide; Gene Expression; Humans; Isoenzymes; Leukemia, Myeloid; RNA, Antisense; RNA, Messenger; Tumor Cells, Cultured | 1998 |
Autologous bone marrow transplantation for acute myeloid leukemia using 4-hydroperoxycyclophosphamide-purged bone marrow and the busulfan/etoposide preparative regimen: a follow-up report.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Disease-Free Survival; Etoposide; Follow-Up Studies; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Middle Aged; Transplantation, Autologous | 1998 |
Treatment of acute myeloid leukemia.
Topics: Bone Marrow Transplantation; Cyclophosphamide; Disease-Free Survival; Humans; Leukemia, Myeloid; Transplantation Conditioning; Transplantation, Autologous | 1999 |
The effect of graft purging with 4-hydroperoxycyclophosphamide in autologous bone marrow transplantation for acute myelogenous leukemia.
Topics: Acute Disease; Adolescent; Adult; Americas; Bone Marrow Purging; Bone Marrow Transplantation; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Female; Graft Survival; Humans; Infant; Leukemia, Myeloid; Life Tables; Male; Middle Aged; Prognosis; Proportional Hazards Models; Registries; Remission Induction; Retrospective Studies; Risk; Survival Analysis; Transplantation, Autologous; Treatment Outcome | 2001 |
Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide purging for acute myeloid leukaemia beyond first remission: a 10-year experience.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Purging; Bone Marrow Transplantation; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Female; Follow-Up Studies; Humans; Infant; Leukemia, Myeloid; Leukocyte Count; Male; Middle Aged; Multivariate Analysis; Neutrophils; Prognosis; Recurrence; Remission Induction; Transplantation, Autologous | 2002 |
Potential of phenylalanine methylester as a bone marrow purging agent.
Topics: Bone Marrow; Bone Marrow Purging; Colony-Forming Units Assay; Cyclophosphamide; Erythropoietin; Hematopoietic Cell Growth Factors; Humans; Kinetics; Leukemia, Myeloid; Leukemia, Promyelocytic, Acute; Phenylalanine; Recombinant Proteins; Stem Cell Factor; Time Factors; Tumor Cells, Cultured | 1992 |
Effect of combined treatment with interleukin-3 and interleukin-6 on 4-hydroperoxycyclophosphamide-mediated reduction of glutathione levels and cytotoxicity in normal and leukemic bone marrow progenitor cells.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Cells, Cultured; Cyclophosphamide; Drug Interactions; Glutathione; Glutathione Transferase; Hematopoietic Stem Cells; Humans; Interleukin-3; Interleukin-6; Leukemia, Myeloid; Tumor Cells, Cultured | 1992 |
Predictive value of colony-forming unit assays for engraftment and leukemia-free survival after transplantation of chemopurged syngeneic bone marrow in rats.
Topics: Acute Disease; Animals; Bleomycin; Bone Marrow; Bone Marrow Transplantation; Colony-Forming Units Assay; Cyclophosphamide; Female; Leukemia, Myeloid; Predictive Value of Tests; Rats; Stem Cells; Transplantation, Isogeneic | 1991 |
The effect of a prolonged in vitro exposure to 1-beta-D arabinofuranosylcytosine and deoxycytidine on the survival of normal (CFU-GM) and leukemic (L-CFU) human myeloid progenitor cells in suspension culture.
Topics: Cell Survival; Culture Media; Cyclophosphamide; Cytarabine; Deoxycytidine; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid; Neoplastic Stem Cells; Phytohemagglutinins; Suspensions; Tumor Cells, Cultured | 1990 |
Suitability of a new stable acetal analogue of aldoifosphamide for purging leukemic cells from human bone marrow.
Topics: Antineoplastic Agents; Bone Marrow; Bone Marrow Cells; Cell Survival; Chemical Phenomena; Chemistry; Cyclophosphamide; Drug Screening Assays, Antitumor; Granulocytes; Hematopoietic Stem Cells; Humans; Ifosfamide; Leukemia, Myeloid; Macrophages; Tumor Cells, Cultured | 1990 |
In vitro restoration of polyclonal hematopoiesis in a chronic myelogenous leukemia after in vitro treatment with 4-hydroperoxycyclophosphamide.
Topics: Bone Marrow Cells; Cells, Cultured; Cyclophosphamide; Female; Glucosephosphate Dehydrogenase; Hematopoiesis; Hematopoietic Stem Cells; Heterozygote; Humans; Leukemia, Myeloid; Middle Aged | 1985 |